Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Deka Biosciences, Inc logo — company profile

Deka Biosciences, Inc

Founded 2018 United States Germantown, United States 40 employees Series Unknown Total: $91.35M Biotechnology, Health Care

General Information

Company Name Deka Biosciences, Inc
Founded Year 2018
Location United States Germantown, United States +1
Employees 40
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Deka Biosciences, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Deka Biosciences, Inc

Deka Biosciences, Inc. is an early-stage biotechnology company founded in 2018 and headquartered in the United States. The company is focused on developing the next generation of targeted cytokine therapies to treat cancer and inflammatory diseases. Their innovative DiakineTM platform consists of optimized, stimulatory, or suppressive disease-specific IL-10 variants coupled to other stimulatory or suppressive cytokines using a T1/2 life-extending, tissue-targeting, non-immunogenic scFv technology. Deka Biosciences recently secured a significant $29.85M in funding on 08 December 2023, which marks a pivotal moment in their financial journey. The investors involved in this latest funding round are not disclosed, but this substantial investment underscores the confidence and potential seen in Deka Biosciences' innovative approach to biotechnology in the healthcare industry.

Taxonomy: cancer therapy, inflammatory diseases, cytokine therapy, IL-10 variants, scFv technology, targeted therapies, biotech startup, immunotherapy, cancer treatment

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 08 Dec 2023
Series B •••••• 10
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		28 Sep 2023
Series B •••••• - 01 Jan 2022
Series A •••••• - 29 Oct 2021

Deka Biosciences, Inc Alternatives & Competitors

Deka Biosciences, Inc vs
Siren Biotechnology
Siren Biotechnology United States

Universal AAV immuno-gene therapy for cancer

Seed
9 employees
Biotechnology
Compare Deka Biosciences, Inc vs Siren Biotechnology
Deka Biosciences, Inc vs
Novelogics Biotechnology Inc.
Novelogics Biotechnology Inc. Canada

Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer using an “In...

Angel
1 employees
Biotechnology, Health Care
Compare Deka Biosciences, Inc vs Novelogics Biotechnology Inc.
Deka Biosciences, Inc vs
Simcha Therapeutics
Simcha Therapeutics United States

Overcoming biological challenges in clinically translatable pathways.

Series B
15 employees
Biotechnology, Health and Wellness
Compare Deka Biosciences, Inc vs Simcha Therapeutics
Also compare with: Deka Biosciences, Inc vs Synthekine Synthekine

FAQ About Deka Biosciences, Inc

Deka Biosciences, Inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases. Deka is developing the dual cytokine, (DiakineTM) platform. Diakines are comprised of optimized, stimulatory, or suppressiv...
Deka Biosciences, Inc was founded in 2018.
Deka Biosciences, Inc is headquartered in Germantown, United States.
Deka Biosciences, Inc operates in the following industries: Biotechnology, Health Care.
Deka Biosciences, Inc has approximately 40 employees.
Deka Biosciences, Inc has completed 4 funding rounds, raising a total of $91.35M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Deka Biosciences, Inc include Siren Biotechnology, Novelogics Biotechnology Inc., Simcha Therapeutics, Synthekine, IO Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Deka Biosciences, Inc and Siren Biotechnology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Deka Biosciences, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy